Literature DB >> 21192729

Screening natural products for inhibitors of quinone reductase-2 using ultrafiltration LC-MS.

Yongsoo Choi1, Katherine Jermihov, Sang-Jip Nam, Megan Sturdy, Katherine Maloney, Xi Qiu, Lucas R Chadwick, Matthew Main, Shao-Nong Chen, Andrew D Mesecar, Norman R Farnsworth, Guido F Pauli, William Fenical, John M Pezzuto, Richard B van Breemen, Richard R van Breemen.   

Abstract

Inhibitors of quinone reductase-2 (NQO2; QR-2) can have antimalarial activity and antitumor activities or can function as chemoprevention agents by preventing the metabolic activation of toxic quinones such as menadione. To expedite the search for new natural product inhibitors of QR-2, we developed a screening assay based on ultrafiltration liquid chromatography-mass spectrometry that is compatible with complex samples such as bacterial or botanical extracts. Human QR-2 was prepared recombinantly, and the known QR-2 inhibitor, resveratrol, was used as a positive control and as a competitive ligand to eliminate false positives. Ultrafiltration LC-MS screening of extracts of marine sediment bacteria resulted in the discovery of tetrangulol methyl ether as an inhibitor of QR-2. When applied to the screening of hop extracts from the botanical, Humulus lupulus L., xanthohumol and xanthohumol D were identified as ligands of QR-2. Inhibition of QR-2 by these ligands was confirmed using a functional enzyme assay. Furthermore, binding of xanthohumol and xanthohumol D to the active site of QR-2 was confirmed using X-ray crystallography. Ultrafiltration LC-MS was shown to be a useful assay for the discovery of inhibitors of QR-2 in complex matrixes such as extracts of bacteria and botanicals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21192729      PMCID: PMC3034444          DOI: 10.1021/ac1028424

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  30 in total

1.  Secondary metabolites by chemical screening. Part 19. SM 196 A and B, novel biologically active angucyclinones from Streptomyces sp.

Authors:  S Grabley; P Hammann; K Hütter; H Kluge; R Thiericke; J Wink; A Zeeck
Journal:  J Antibiot (Tokyo)       Date:  1991-06       Impact factor: 2.649

2.  Pulsed ultrafiltration mass spectrometry: a new method for screening combinatorial libraries.

Authors:  R B van Breemen; C R Huang; D Nikolic; C P Woodbury; Y Z Zhao; D L Venton
Journal:  Anal Chem       Date:  1997-06-01       Impact factor: 6.986

Review 3.  NRH:quinone oxidoreductase2 (NQO2).

Authors:  D J Long; A K Jaiswal
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

4.  Discovery of novel targets of quinoline drugs in the human purine binding proteome.

Authors:  Paul R Graves; Jesse J Kwiek; Patrick Fadden; Rupa Ray; Klaas Hardeman; Andrew M Coley; Michael Foley; Timothy A J Haystead
Journal:  Mol Pharmacol       Date:  2002-12       Impact factor: 4.436

5.  The structural characterization of tetrangomycin and tetrangulol.

Authors:  M P Kuntsmann; L A Mitscher
Journal:  J Org Chem       Date:  1966-09       Impact factor: 4.354

6.  Estrogens and congeners from spent hops (Humulus lupulus).

Authors:  Lucas R Chadwick; Dejan Nikolic; Joanna E Burdette; Cassia R Overk; Judy L Bolton; Richard B van Breemen; Roland Fröhlich; Harry H S Fong; Norman R Farnsworth; Guido F Pauli
Journal:  J Nat Prod       Date:  2004-12       Impact factor: 4.050

7.  Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines.

Authors:  Jesse J Kwiek; Timothy A J Haystead; Johannes Rudolph
Journal:  Biochemistry       Date:  2004-04-20       Impact factor: 3.162

8.  Crystal structure of quinone reductase 2 in complex with resveratrol.

Authors:  Leonid Buryanovskyy; Yue Fu; Molly Boyd; Yuliang Ma; Tze-chen Hsieh; Joseph M Wu; Zhongtao Zhang
Journal:  Biochemistry       Date:  2004-09-14       Impact factor: 3.162

9.  Microbial products. VI Five novel metabolites related to benz[a]anthracene from an unidentified actinomycete designated X-14881.

Authors:  H Maehr; C M Liu; M Liu; A Perrotta; J M Smallheer; T H Williams; J F Blount
Journal:  J Antibiot (Tokyo)       Date:  1982-12       Impact factor: 2.649

Review 10.  CB 1954: from the Walker tumor to NQO2 and VDEPT.

Authors:  Richard J Knox; Philip J Burke; Shiuan Chen; David J Kerr
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

View more
  13 in total

1.  Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity.

Authors:  Tamara P Kondratyuk; Eun-Jung Park; Laura E Marler; Soyoun Ahn; Yang Yuan; Yongsoo Choi; Rui Yu; Richard B van Breemen; Bin Sun; Juma Hoshino; Mark Cushman; Katherine C Jermihov; Andrew D Mesecar; Clinton J Grubbs; John M Pezzuto
Journal:  Mol Nutr Food Res       Date:  2011-06-29       Impact factor: 5.914

Review 2.  Drug discovery from natural products using affinity selection-mass spectrometry.

Authors:  Ruth N Muchiri; Richard B van Breemen
Journal:  Drug Discov Today Technol       Date:  2021-10-21

3.  Potential Multifunctional Bioactive Compounds from Dysosma versipellis Explored by Bioaffinity Ultrafiltration-HPLC/MS with Topo I, Topo II, COX-2 and ACE2.

Authors:  Huixia Feng; Guilin Chen; Yongli Zhang; Mingquan Guo
Journal:  J Inflamm Res       Date:  2022-08-15

4.  Identification of Streptomyces sp. nov. WH26 producing cytotoxic compounds isolated from marine solar saltern in China.

Authors:  Haizhou Liu; Lin Xiao; Jianteng Wei; John C Schmitz; Ming Liu; Cuicui Wang; Linyou Cheng; Ning Wu; Lei Chen; Yuyan Zhang; Xiukun Lin
Journal:  World J Microbiol Biotechnol       Date:  2013-02-19       Impact factor: 3.312

Review 5.  Comparison of analytical techniques for the identification of bioactive compounds from natural products.

Authors:  Łukasz Cieśla; Ruin Moaddel
Journal:  Nat Prod Rep       Date:  2016-07-01       Impact factor: 13.423

Review 6.  Matching the power of high throughput screening to the chemical diversity of natural products.

Authors:  Curtis J Henrich; John A Beutler
Journal:  Nat Prod Rep       Date:  2013-08-08       Impact factor: 13.423

7.  A ligand-observed mass spectrometry approach integrated into the fragment based lead discovery pipeline.

Authors:  Xin Chen; Shanshan Qin; Shuai Chen; Jinlong Li; Lixin Li; Zhongling Wang; Quan Wang; Jianping Lin; Cheng Yang; Wenqing Shui
Journal:  Sci Rep       Date:  2015-02-10       Impact factor: 4.379

Review 8.  Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2013-07-16       Impact factor: 5.118

9.  Novel Chemical Ligands to Ebola Virus and Marburg Virus Nucleoproteins Identified by Combining Affinity Mass Spectrometry and Metabolomics Approaches.

Authors:  Xu Fu; Zhihua Wang; Lixin Li; Shishang Dong; Zhucui Li; Zhenzuo Jiang; Yuefei Wang; Wenqing Shui
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

10.  High-throughput identification of G protein-coupled receptor modulators through affinity mass spectrometry screening.

Authors:  Shanshan Qin; Mengmeng Meng; Dehua Yang; Wenwen Bai; Yan Lu; Yao Peng; Gaojie Song; Yiran Wu; Qingtong Zhou; Suwen Zhao; Xiping Huang; John D McCorvy; Xiaoqing Cai; Antao Dai; Bryan L Roth; Michael A Hanson; Zhi-Jie Liu; Ming-Wei Wang; Raymond C Stevens; Wenqing Shui
Journal:  Chem Sci       Date:  2018-02-20       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.